Hodgkin lymphoma survival has nearly tripled since the 1950s

 

Five-year relative survival for Hodgkin lymphoma increased 189% over the approximately 60 years from the early 1950s to 2013, according to investigators looking at data from the Surveillance, Epidemiology, and End Results Program.

During 1950-1954, the 5-year relative survival rate for Hodgkin lymphoma was 30%, compared with 86.6% in 2008-2013, said Ali H. Mokdad, PhD, and his associates at the Institute for Health Metrics and Evaluation at the University of Washington, Seattle.

Hodgkin lymphoma was 1 of only 6 of the 29 cancers included in the analysis that had a 5-year survival rate of above 85%. The other five were breast cancer, melanoma, prostate cancer, testicular cancer, and thyroid cancer, the investigators noted (JAMA 2017;317[4]:388-406).

In 2014, mortality for Hodgkin lymphoma was 0.4 per 100,000 population, which put it 27th among the 29 included cancers, with about 36,000 years of life lost, which was 26th of the 29 cancers, Dr. Mokdad and his associates said. This part of their study used deidentified death records from the National Center for Health Statistics and population counts from the Census Bureau, the NCHS, and the Human Mortality Database.

[email protected]

 

Five-year relative survival for Hodgkin lymphoma increased 189% over the approximately 60 years from the early 1950s to 2013, according to investigators looking at data from the Surveillance, Epidemiology, and End Results Program.

During 1950-1954, the 5-year relative survival rate for Hodgkin lymphoma was 30%, compared with 86.6% in 2008-2013, said Ali H. Mokdad, PhD, and his associates at the Institute for Health Metrics and Evaluation at the University of Washington, Seattle.

Hodgkin lymphoma was 1 of only 6 of the 29 cancers included in the analysis that had a 5-year survival rate of above 85%. The other five were breast cancer, melanoma, prostate cancer, testicular cancer, and thyroid cancer, the investigators noted (JAMA 2017;317[4]:388-406).

In 2014, mortality for Hodgkin lymphoma was 0.4 per 100,000 population, which put it 27th among the 29 included cancers, with about 36,000 years of life lost, which was 26th of the 29 cancers, Dr. Mokdad and his associates said. This part of their study used deidentified death records from the National Center for Health Statistics and population counts from the Census Bureau, the NCHS, and the Human Mortality Database.

[email protected]

 

Five-year relative survival for Hodgkin lymphoma increased 189% over the approximately 60 years from the early 1950s to 2013, according to investigators looking at data from the Surveillance, Epidemiology, and End Results Program.

During 1950-1954, the 5-year relative survival rate for Hodgkin lymphoma was 30%, compared with 86.6% in 2008-2013, said Ali H. Mokdad, PhD, and his associates at the Institute for Health Metrics and Evaluation at the University of Washington, Seattle.

Hodgkin lymphoma was 1 of only 6 of the 29 cancers included in the analysis that had a 5-year survival rate of above 85%. The other five were breast cancer, melanoma, prostate cancer, testicular cancer, and thyroid cancer, the investigators noted (JAMA 2017;317[4]:388-406).

In 2014, mortality for Hodgkin lymphoma was 0.4 per 100,000 population, which put it 27th among the 29 included cancers, with about 36,000 years of life lost, which was 26th of the 29 cancers, Dr. Mokdad and his associates said. This part of their study used deidentified death records from the National Center for Health Statistics and population counts from the Census Bureau, the NCHS, and the Human Mortality Database.

[email protected]